Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| Weiss Ratings | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 110.33 | |||
| Price History | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -100.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.65 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 02, 2024 | |||
| 52-Week High Price (Date) | Apr 10, 2024 | |||
| Valuation | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.00 | |||
| Enterprise Value | 32.43M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -8.36 | |||
| Earnings Per Share Growth | -12.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.63 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.27 | |||
| Enterprise Value/EBIT | -0.95 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.87M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 855 646 7874 | |||
| Address | 4255 Burton Drive Santa Clara, CA 95054 | |||
| Website | minervasurgical.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -66.26% | |||
| Profit Margin | -64.70% | |||
| Management Effectiveness | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -27.35% | |||
| Return on Equity | -- | |||
| Income Statement | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 51.69M | |||
| Total Revenue (TTM) | 51.69M | |||
| Revenue Per Share | $5.83 | |||
| Gross Profit (TTM) | 28.01M | |||
| EBITDA (TTM) | -25.56M | |||
| EBIT (TTM) | -34.26M | |||
| Net Income (TTM) | -33.45M | |||
| Net Income Avl. to Common (TTM) | -33.45M | |||
| Total Revenue Growth (Q YOY) | -4.95% | |||
| Earnings Growth (Q YOY) | 36.61% | |||
| EPS Diluted (TTM) | -8.36 | |||
| EPS Diluted Growth (Q YOY) | 89.78% | |||
| Balance Sheet | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.13M | |||
| Cash Per Share (Q) | $1.25 | |||
| Total Current Assets (Q) | 40.00M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 20.26M | |||
| Current Ratio (Q) | 1.882 | |||
| Book Value Per Share (Q) | $2.28 | |||
| Total Assets (Q) | 72.79M | |||
| Total Current Liabilities (Q) | 21.25M | |||
| Total Debt (Q) | 43.55M | |||
| Total Liabilities (Q) | 52.53M | |||
| Total Common Equity (Q) | 20.26M | |||
| Cash Flow | UTRS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -53.00K | |||
| Cash from Financing (TTM) | 26.86M | |||
| Net Change in Cash (TTM) | -11.93M | |||
| Levered Free Cash Flow (TTM) | -18.49M | |||
| Cash from Operations (TTM) | -38.73M | |||
